SEC Form 4 research
| Issuer | Calidi Biotherapeutics, Inc. |
|---|---|
| Tickers | CLDI, FLAG |
| Reporting owners | 33 |
| Officers and directors | 5 |
| Last public filing | 2026-08-20 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-19 | 2026-08-17 | Peoples George | A | 4,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-17 | Stewart Alan R. | A | 4,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-17 | Leftwich Scott | A | 4,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-17 | Jackson Andrew C. | A | 14,000 | Not reported | Not reported |
| 2026-08-19 | 2026-08-17 | Schoeneck James A | A | 5,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-17 | Poma Eric E | A | 32,000 | Not reported | Not reported |
| 2026-08-19 | 2026-08-17 | Fernandez Santidrian Antonio | A | 16,000 | Not reported | Not reported |
| 2026-08-19 | 2026-08-17 | Sanders Corazon (Corsee) D. | A | 6,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.